Thanks, Rohit. Good morning, everyone. We delivered another set of very strong results in the first quarter of 2025. GAAP net income was $166 million or $1.08 per diluted share compared to $1.01 per diluted share in the same period last year, and $1.05 per diluted share in the fourth quarter of 2024. Return on equity was 13.1%. Adjusted operating income was $169 million or $1.10 per diluted share compared to $1.04 per diluted share in the same period last year, and $1.09 per diluted share in the fourth quarter of 2024. Adjusted operating return on equity was 13.4%. Turning to revenue drivers. New insurance written was $10 billion, down 26% sequentially and down 7% year-over-year. Purchase originations were seasonally lower, and mortgage activity remained muted, as elevated mortgage rates and home prices pressured affordability. Persistency was 84% in the first quarter, up 2 points sequentially and down 1 point year-over-year. Our portfolio remains resilient to mortgage rate volatility with 8% of the mortgages in our portfolio, having rates at least 50 basis points above March's average mortgage rate of 6.7%. Looking ahead, we anticipate the elevated persistency will continue to help offset any impact of higher mortgage rates that could reduce the size of the origination market. Given the combination of lower new insurance written and elevated persistency primary insurance in-force was $268 billion in the first quarter, relatively flat from $269 billion in the fourth quarter of 2024, and up $4 billion or 2% year-over-year. Total net premiums earned were $245 million, down $1 million sequentially and up $4 million or 2% year-over-year. The decrease sequentially was driven by higher ceded premiums, while the year-over-year increase was primarily driven by premium growth from attractive adjacencies and the growth of our mortgage insurance portfolio, partially offset by higher ceded premiums. Turning to primary premiums. Our base premium rate of 40.1 basis points was relatively flat sequentially, which align with our guidance that we expect our base premium rate in 2025 to stabilize around 2024 levels. As a reminder, our base premium rate is impacted by several factors and tends to modestly fluctuate from quarter-to-quarter. Our net earned premium rate was 35.3 basis points, down 0.2 basis points sequentially, driven primarily by higher ceded premiums and lower single premium cancellations. Investment income in the first quarter was $63 million, flat sequentially and up $6 million or 11% year-over-year. During the quarter, our new money investment yield continue to exceed 5%, lifting our overall portfolio book yield by 10 basis points to 4.1%. Our focus remains on investing in high-quality assets and maintaining a resilient diversified A-rated portfolio. As we have previously stated, while we typically hold investments to maturity, we may selectively pursue income enhancement opportunities. During the quarter, we sold certain assets that will allow us to recoup approximately $3 million of realized losses through future higher net investment income. We still view our investment portfolio's unrealized loss position as materially non-economic. Turning to credit performance. New delinquencies decreased sequentially to 12,200 in the quarter from 13,700 in the fourth quarter of 2024. After adjusting for the estimated 1,000 hurricane-related new delinquencies reported in the fourth quarter of 2024, the 5% sequential decrease in new delinquencies is in line with expected seasonal trends. Our new delinquency rate remained consistent with pre-pandemic levels and for the quarter was 1.3%, a decrease of 20 basis points compared to the 1.5% in the fourth quarter of 2024, and 1.2% in the first quarter of 2024. We maintained our claim rate on new delinquencies at 9% for the quarter. There were no material hurricane-related delinquencies reported in the quarter, and consequently, we made no adjustments to our claim rates during the quarter. Total delinquencies in the first quarter decreased sequentially to 22,300 from 23,600, as cures outpaced news. The primary delinquency rate for the quarter was 2.3% compared to 2.4% in the fourth quarter of 2024, and 2% in the first quarter of 2024. Losses in the first quarter of 2025 were $31 million and the loss ratio was 12%, compared to $24 million and 10%, respectively, in the fourth quarter of 2024 and $20 million and 8%, respectively, in the first quarter of 2024. The current quarter reserve release of $47 million from favorable cure performance and loss mitigation activities compared to a reserve release of $56 million and $54 million in the fourth quarter of 2024 and the first quarter of 2024, respectively. Our losses and loss ratio increased sequentially and year-over-year, primarily driven by a lower reserve release in the current quarter. The year-over-year increase was also driven by incremental new delinquencies, partially offset by a lower claim rate assumption. Turning to operating expenses. Operating expenses for the first quarter of 2025 were $53 million and the expense ratio was 21% compared to $58 million and 24%, respectively, in the fourth quarter of 2024, and $53 million and 22%, respectively, in the first quarter of 2024. First quarter operating expenses included approximately $1 million of reorganization costs. For 2025 operating expenses, we continue to anticipate a range of $220 million to $225 million, excluding reorganization costs, as we continue to prudently manage our expense base, while also investing in growth initiatives and modernization driving future efficiencies in addition to normal inflationary dynamics. We continue to operate from a strong capital and liquidity position, reinforced by our robust PMIER Sufficiency and the successful execution of our diversified CRT program. Our PMIERs Sufficiency was 165% or $2 billion above PMIERs requirements at the end of the first quarter. As of March 31, 2025, our third-party CRT program provides $1.9 billion of PMIERs capital credit. As a reminder, we have executed both forward quota share and forward excess of loss reinsurance transactions on our 2025 and 2026 book years, which we expect will provide meaningful PMIERs credit over time and loss protection on these book years as they age through an uncertain macroeconomic backdrop. Let me now turn to capital allocation. During the quarter, we paid out $28 million or $0.185 per share through our quarterly dividend and bought back 2 million shares at a weighted average share price of $33.38 for a total of approximately $66 million. Through April '25, we repurchased an additional 600,000 shares at a weighted average share price of $34.53 for a total of $21 million. Yesterday, we announced a 14% increase to our quarterly dividend from $0.185 per share to $0.21 per share, and the Board approved a new share repurchase authorization of $350 million. In support of the new share repurchase authorization, Enact is entered into an agreement with Genworth to repurchase its Enact shares as part of the program to maintain Genworth's current ownership interest in Enact. Combining this new authorization with our remaining $6 million capacity under our May 2024 authorization, we have a total buyback authorization of $356 million available as of April 25, 2025. Both the increased dividend and new share repurchase authorization actions reflect the continued strength of our financial position and confidence in our business. As Rohit mentioned earlier, our 2025 total capital return guidance remains unchanged at $350 million. As in the past, the final amount and form of capital return to shareholders will ultimately depend on business performance, market conditions and regulatory approvals. Overall, we're pleased with our strong start to 2025 and remain focused on prudently managing risk, maintaining a strong balance sheet and driving solid returns for our shareholders. With that, let me turn the call back to Rohit.